BiomX Inc.
PHGE-WT
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.88M
Close$
Share Statistics
| Market cap | $1.88 Million |
|---|---|
| Enterprise Value | $4.90 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 684.26% |
|---|---|
| Return on Assets | 263.77% |
| Return on Invested Capital | 156.41% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 14.77 |
| Enterprise Value to EBIT | 0.17 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.69 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BiomX Inc
101 employees
CEO: Michael Oster BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic dis...